NCT01670721View on ClinicalTrials.gov

Colorectal Cancer Metastatic

PHASE3CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

AFLIBERCEPT

Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous

DRUG

Irinotecan

Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous

DRUG

Fluorouracil

Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous

DRUG

Leucovorin

Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous

Trial Locations (1)

Unknown

Administrative office, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT01670721 - Colorectal Cancer Metastatic | Biotech Hunter | Biotech Hunter